Gene symbol: Syk

Also known as: p72syk

Organism: Rattus norvegicus

Summary: Enables protein domain specific binding activity; protein tyrosine kinase activity; and ubiquitin protein ligase binding activity. Involved in positive regulation of mast cell degranulation and protein autophosphorylation. Predicted to be located in early phagosome and nucleus. Predicted to be part of B cell receptor complex and T cell receptor complex. Predicted to be extrinsic component of cytoplasmic side of plasma membrane. Used to study anti-basement membrane glomerulonephritis. Human ortholog(s) of this gene implicated in primary immunodeficiency disease. Orthologous to human SYK (spleen associated tyrosine kinase). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 25155 Ensembl:ENSRNOG00000012160 AllianceGenome:RGD:3796


GO Annotation


Category Term ID Term description
Process GO:0001525 Angiogenesis
Process GO:0001568 Blood vessel development
Process GO:0001775 Cell activation
Process GO:0001817 Regulation of cytokine production
Process GO:0001819 Positive regulation of cytokine production
Process GO:0001820 Serotonin secretion
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001944 Vasculature development
Process GO:0001945 Lymph vessel development
Process GO:0001959 Regulation of cytokine-mediated signaling pathway
Process GO:0002090 Regulation of receptor internalization
Process GO:0002092 Positive regulation of receptor internalization
Process GO:0002218 Activation of innate immune response
Process GO:0002220 Innate immune response activating cell surface receptor signaling pathway
Process GO:0002223 Stimulatory C-type lectin receptor signaling pathway
Process GO:0002238 Response to molecule of fungal origin
Process GO:0002250 Adaptive immune response
Process GO:0002252 Immune effector process
Process GO:0002253 Activation of immune response
Process GO:0002263 Cell activation involved in immune response
Process GO:0002274 Myeloid leukocyte activation
Process GO:0002275 Myeloid cell activation involved in immune response
Process GO:0002279 Mast cell activation involved in immune response
Process GO:0002281 Macrophage activation involved in immune response
Process GO:0002283 Neutrophil activation involved in immune response
Process GO:0002351 Serotonin production involved in inflammatory response
Process GO:0002366 Leukocyte activation involved in immune response
Process GO:0002376 Immune system process
Process GO:0002429 Immune response-activating cell surface receptor signaling pathway
Process GO:0002442 Serotonin secretion involved in inflammatory response
Process GO:0002443 Leukocyte mediated immunity
Process GO:0002444 Myeloid leukocyte mediated immunity
Process GO:0002448 Mast cell mediated immunity
Process GO:0002520 Immune system development
Process GO:0002521 Leukocyte differentiation
Process GO:0002532 Production of molecular mediator involved in inflammatory response
Process GO:0002554 Serotonin secretion by platelet
Process GO:0002576 Platelet degranulation
Process GO:0002682 Regulation of immune system process
Process GO:0002684 Positive regulation of immune system process
Process GO:0002694 Regulation of leukocyte activation
Process GO:0002696 Positive regulation of leukocyte activation
Process GO:0002697 Regulation of immune effector process
Process GO:0002699 Positive regulation of immune effector process
Process GO:0002700 Regulation of production of molecular mediator of immune response
Process GO:0002702 Positive regulation of production of molecular mediator of immune response
Process GO:0002703 Regulation of leukocyte mediated immunity
Process GO:0002718 Regulation of cytokine production involved in immune response
Process GO:0002720 Positive regulation of cytokine production involved in immune response
Process GO:0002757 Immune response-activating signal transduction
Process GO:0002758 Innate immune response-activating signal transduction
Process GO:0002764 Immune response-regulating signaling pathway
Process GO:0002768 Immune response-regulating cell surface receptor signaling pathway
Process GO:0002831 Regulation of response to biotic stimulus
Process GO:0002833 Positive regulation of response to biotic stimulus
Process GO:0002886 Regulation of myeloid leukocyte mediated immunity
Process GO:0006082 Organic acid metabolic process
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006468 Protein phosphorylation
Process GO:0006606 Protein import into nucleus
Process GO:0006690 Icosanoid metabolic process
Process GO:0006691 Leukotriene metabolic process
Process GO:0006793 Phosphorus metabolic process
Process GO:0006796 Phosphate-containing compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006810 Transport
Process GO:0006811 Ion transport
Process GO:0006812 Cation transport
Process GO:0006837 Serotonin transport
Process GO:0006886 Intracellular protein transport
Process GO:0006887 Exocytosis
Process GO:0006897 Endocytosis
Process GO:0006898 Receptor-mediated endocytosis
Process GO:0006913 Nucleocytoplasmic transport
Process GO:0006935 Chemotaxis
Process GO:0006950 Response to stress
Process GO:0006952 Defense response
Process GO:0006954 Inflammatory response
Process GO:0006955 Immune response
Process GO:0007154 Cell communication
Process GO:0007155 Cell adhesion
Process GO:0007159 Leukocyte cell-cell adhesion
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007167 Enzyme-linked receptor protein signaling pathway
Process GO:0007169 Transmembrane receptor protein tyrosine kinase signaling pathway
Process GO:0007229 Integrin-mediated signaling pathway
Process GO:0007267 Cell-cell signaling
Process GO:0007275 Multicellular organism development
Process GO:0008104 Protein localization
Process GO:0008152 Metabolic process
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0009058 Biosynthetic process
Process GO:0009605 Response to external stimulus
Process GO:0009607 Response to biotic stimulus
Process GO:0009617 Response to bacterium
Process GO:0009620 Response to fungus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009719 Response to endogenous stimulus
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010468 Regulation of gene expression
Process GO:0010543 Regulation of platelet activation
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010803 Regulation of tumor necrosis factor-mediated signaling pathway
Process GO:0010941 Regulation of cell death
Process GO:0010942 Positive regulation of cell death
Process GO:0010950 Positive regulation of endopeptidase activity
Process GO:0010952 Positive regulation of peptidase activity
Process GO:0015031 Protein transport
Process GO:0015844 Monoamine transport
Process GO:0015850 Organic hydroxy compound transport
Process GO:0016053 Organic acid biosynthetic process
Process GO:0016192 Vesicle-mediated transport
Process GO:0016310 Phosphorylation
Process GO:0016477 Cell migration
Process GO:0017157 Regulation of exocytosis
Process GO:0018105 Peptidyl-serine phosphorylation
Process GO:0018108 Peptidyl-tyrosine phosphorylation
Process GO:0018193 Peptidyl-amino acid modification
Process GO:0018209 Peptidyl-serine modification
Process GO:0018212 Peptidyl-tyrosine modification
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019221 Cytokine-mediated signaling pathway
Process GO:0019222 Regulation of metabolic process
Process GO:0019370 Leukotriene biosynthetic process
Process GO:0019538 Protein metabolic process
Process GO:0019722 Calcium-mediated signaling
Process GO:0019752 Carboxylic acid metabolic process
Process GO:0019932 Second-messenger-mediated signaling
Process GO:0022407 Regulation of cell-cell adhesion
Process GO:0022409 Positive regulation of cell-cell adhesion
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023061 Signal release
Process GO:0030097 Hemopoiesis
Process GO:0030098 Lymphocyte differentiation
Process GO:0030100 Regulation of endocytosis
Process GO:0030154 Cell differentiation
Process GO:0030155 Regulation of cell adhesion
Process GO:0030162 Regulation of proteolysis
Process GO:0030183 B cell differentiation
Process GO:0030217 T cell differentiation
Process GO:0030593 Neutrophil chemotaxis
Process GO:0030595 Leukocyte chemotaxis
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031334 Positive regulation of protein-containing complex assembly
Process GO:0031341 Regulation of cell killing
Process GO:0031343 Positive regulation of cell killing
Process GO:0031347 Regulation of defense response
Process GO:0031349 Positive regulation of defense response
Process GO:0031399 Regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0031623 Receptor internalization
Process GO:0031952 Regulation of protein autophosphorylation
Process GO:0031954 Positive regulation of protein autophosphorylation
Process GO:0032101 Regulation of response to external stimulus
Process GO:0032103 Positive regulation of response to external stimulus
Process GO:0032303 Regulation of icosanoid secretion
Process GO:0032368 Regulation of lipid transport
Process GO:0032418 Lysosome localization
Process GO:0032479 Regulation of type I interferon production
Process GO:0032481 Positive regulation of type I interferon production
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032642 Regulation of chemokine production
Process GO:0032645 Regulation of granulocyte macrophage colony-stimulating factor production
Process GO:0032653 Regulation of interleukin-10 production
Process GO:0032655 Regulation of interleukin-12 production
Process GO:0032672 Regulation of interleukin-3 production
Process GO:0032673 Regulation of interleukin-4 production
Process GO:0032675 Regulation of interleukin-6 production
Process GO:0032677 Regulation of interleukin-8 production
Process GO:0032680 Regulation of tumor necrosis factor production
Process GO:0032722 Positive regulation of chemokine production
Process GO:0032725 Positive regulation of granulocyte macrophage colony-stimulating factor production
Process GO:0032733 Positive regulation of interleukin-10 production
Process GO:0032735 Positive regulation of interleukin-12 production
Process GO:0032752 Positive regulation of interleukin-3 production
Process GO:0032753 Positive regulation of interleukin-4 production
Process GO:0032755 Positive regulation of interleukin-6 production
Process GO:0032757 Positive regulation of interleukin-8 production
Process GO:0032760 Positive regulation of tumor necrosis factor production
Process GO:0032763 Regulation of mast cell cytokine production
Process GO:0032765 Positive regulation of mast cell cytokine production
Process GO:0032879 Regulation of localization
Process GO:0032890 Regulation of organic acid transport
Process GO:0032928 Regulation of superoxide anion generation
Process GO:0032930 Positive regulation of superoxide anion generation
Process GO:0032940 Secretion by cell
Process GO:0032944 Regulation of mononuclear cell proliferation
Process GO:0032946 Positive regulation of mononuclear cell proliferation
Process GO:0033003 Regulation of mast cell activation
Process GO:0033005 Positive regulation of mast cell activation
Process GO:0033006 Regulation of mast cell activation involved in immune response
Process GO:0033008 Positive regulation of mast cell activation involved in immune response
Process GO:0033036 Macromolecule localization
Process GO:0033365 Protein localization to organelle
Process GO:0033628 Regulation of cell adhesion mediated by integrin
Process GO:0033630 Positive regulation of cell adhesion mediated by integrin
Process GO:0033674 Positive regulation of kinase activity
Process GO:0033993 Response to lipid
Process GO:0034097 Response to cytokine
Process GO:0034103 Regulation of tissue remodeling
Process GO:0034110 Regulation of homotypic cell-cell adhesion
Process GO:0034504 Protein localization to nucleus
Process GO:0035239 Tube morphogenesis
Process GO:0035295 Tube development
Process GO:0035556 Intracellular signal transduction
Process GO:0035821 Modulation of process of another organism
Process GO:0036211 Protein modification process
Process GO:0036230 Granulocyte activation
Process GO:0038063 Collagen-activated tyrosine kinase receptor signaling pathway
Process GO:0038065 Collagen-activated signaling pathway
Process GO:0038156 interleukin-3-mediated signaling pathway
Process GO:0040011 Locomotion
Process GO:0042102 Positive regulation of T cell proliferation
Process GO:0042110 T cell activation
Process GO:0042113 B cell activation
Process GO:0042116 Macrophage activation
Process GO:0042119 Neutrophil activation
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042129 Regulation of T cell proliferation
Process GO:0042221 Response to chemical
Process GO:0042325 Regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042330 Taxis
Process GO:0042492 Gamma-delta T cell differentiation
Process GO:0042742 Defense response to bacterium
Process GO:0043067 Regulation of programmed cell death
Process GO:0043068 Positive regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043170 Macromolecule metabolic process
Process GO:0043207 Response to external biotic stimulus
Process GO:0043254 Regulation of protein-containing complex assembly
Process GO:0043269 Regulation of ion transport
Process GO:0043280 Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
Process GO:0043281 Regulation of cysteine-type endopeptidase activity involved in apoptotic process
Process GO:0043299 Leukocyte degranulation
Process GO:0043300 Regulation of leukocyte degranulation
Process GO:0043302 Positive regulation of leukocyte degranulation
Process GO:0043303 Mast cell degranulation
Process GO:0043304 Regulation of mast cell degranulation
Process GO:0043306 Positive regulation of mast cell degranulation
Process GO:0043313 Regulation of neutrophil degranulation
Process GO:0043366 Beta selection
Process GO:0043405 Regulation of MAP kinase activity
Process GO:0043406 Positive regulation of MAP kinase activity
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0043412 Macromolecule modification
Process GO:0043436 Oxoacid metabolic process
Process GO:0043506 Regulation of JUN kinase activity
Process GO:0043507 Positive regulation of JUN kinase activity
Process GO:0043549 Regulation of kinase activity
Process GO:0044070 Regulation of anion transport
Process GO:0044087 Regulation of cellular component biogenesis
Process GO:0044089 Positive regulation of cellular component biogenesis
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044281 Small molecule metabolic process
Process GO:0044283 Small molecule biosynthetic process
Process GO:0044419 Biological process involved in interspecies interaction between organisms
Process GO:0045055 Regulated exocytosis
Process GO:0045058 T cell selection
Process GO:0045087 Innate immune response
Process GO:0045088 Regulation of innate immune response
Process GO:0045089 Positive regulation of innate immune response
Process GO:0045124 Regulation of bone resorption
Process GO:0045184 Establishment of protein localization
Process GO:0045321 Leukocyte activation
Process GO:0045576 Mast cell activation
Process GO:0045577 Regulation of B cell differentiation
Process GO:0045579 Positive regulation of B cell differentiation
Process GO:0045580 Regulation of T cell differentiation
Process GO:0045582 Positive regulation of T cell differentiation
Process GO:0045586 Regulation of gamma-delta T cell differentiation
Process GO:0045588 Positive regulation of gamma-delta T cell differentiation
Process GO:0045595 Regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045619 Regulation of lymphocyte differentiation
Process GO:0045621 Positive regulation of lymphocyte differentiation
Process GO:0045780 Positive regulation of bone resorption
Process GO:0045785 Positive regulation of cell adhesion
Process GO:0045807 Positive regulation of endocytosis
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045860 Positive regulation of protein kinase activity
Process GO:0045862 Positive regulation of proteolysis
Process GO:0045921 Positive regulation of exocytosis
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0046394 Carboxylic acid biosynthetic process
Process GO:0046456 Icosanoid biosynthetic process
Process GO:0046629 Gamma-delta T cell activation
Process GO:0046631 Alpha-beta T cell activation
Process GO:0046632 Alpha-beta T cell differentiation
Process GO:0046634 Regulation of alpha-beta T cell activation
Process GO:0046635 Positive regulation of alpha-beta T cell activation
Process GO:0046637 Regulation of alpha-beta T cell differentiation
Process GO:0046638 Positive regulation of alpha-beta T cell differentiation
Process GO:0046640 Regulation of alpha-beta T cell proliferation
Process GO:0046641 Positive regulation of alpha-beta T cell proliferation
Process GO:0046643 Regulation of gamma-delta T cell activation
Process GO:0046645 Positive regulation of gamma-delta T cell activation
Process GO:0046649 Lymphocyte activation
Process GO:0046777 Protein autophosphorylation
Process GO:0046850 Regulation of bone remodeling
Process GO:0046903 Secretion
Process GO:0046907 Intracellular transport
Process GO:0048259 Regulation of receptor-mediated endocytosis
Process GO:0048260 Positive regulation of receptor-mediated endocytosis
Process GO:0048513 Animal organ development
Process GO:0048514 Blood vessel morphogenesis
Process GO:0048518 Positive regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048534 Hematopoietic or lymphoid organ development
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048731 System development
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0048870 Cell motility
Process GO:0050670 Regulation of lymphocyte proliferation
Process GO:0050671 Positive regulation of lymphocyte proliferation
Process GO:0050730 Regulation of peptidyl-tyrosine phosphorylation
Process GO:0050731 Positive regulation of peptidyl-tyrosine phosphorylation
Process GO:0050764 Regulation of phagocytosis
Process GO:0050776 Regulation of immune response
Process GO:0050778 Positive regulation of immune response
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050848 Regulation of calcium-mediated signaling
Process GO:0050850 Positive regulation of calcium-mediated signaling
Process GO:0050851 Antigen receptor-mediated signaling pathway
Process GO:0050853 B cell receptor signaling pathway
Process GO:0050863 Regulation of T cell activation
Process GO:0050864 Regulation of B cell activation
Process GO:0050865 Regulation of cell activation
Process GO:0050867 Positive regulation of cell activation
Process GO:0050870 Positive regulation of T cell activation
Process GO:0050871 Positive regulation of B cell activation
Process GO:0050896 Response to stimulus
Process GO:0050900 Leukocyte migration
Process GO:0051046 Regulation of secretion
Process GO:0051047 Positive regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051090 Regulation of DNA-binding transcription factor activity
Process GO:0051094 Positive regulation of developmental process
Process GO:0051128 Regulation of cellular component organization
Process GO:0051130 Positive regulation of cellular component organization
Process GO:0051169 Nuclear transport
Process GO:0051170 Import into nucleus
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051249 Regulation of lymphocyte activation
Process GO:0051251 Positive regulation of lymphocyte activation
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051338 Regulation of transferase activity
Process GO:0051345 Positive regulation of hydrolase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051640 Organelle localization
Process GO:0051641 Cellular localization
Process GO:0051649 Establishment of localization in cell
Process GO:0051656 Establishment of organelle localization
Process GO:0051707 Response to other organism
Process GO:0051709 Regulation of killing of cells of another organism
Process GO:0051712 Positive regulation of killing of cells of another organism
Process GO:0051716 Cellular response to stimulus
Process GO:0052547 Regulation of peptidase activity
Process GO:0052548 Regulation of endopeptidase activity
Process GO:0055094 Response to lipoprotein particle
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060326 Cell chemotaxis
Process GO:0060627 Regulation of vesicle-mediated transport
Process GO:0060759 Regulation of response to cytokine stimulus
Process GO:0061081 Positive regulation of myeloid leukocyte cytokine production involved in immune response
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070372 Regulation of ERK1 and ERK2 cascade
Process GO:0070663 Regulation of leukocyte proliferation
Process GO:0070665 Positive regulation of leukocyte proliferation
Process GO:0070727 Cellular macromolecule localization
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071216 Cellular response to biotic stimulus
Process GO:0071226 Cellular response to molecule of fungal origin
Process GO:0071310 Cellular response to organic substance
Process GO:0071345 Cellular response to cytokine stimulus
Process GO:0071396 Cellular response to lipid
Process GO:0071402 Cellular response to lipoprotein particle stimulus
Process GO:0071404 Cellular response to low-density lipoprotein particle stimulus
Process GO:0071621 Granulocyte chemotaxis
Process GO:0071637 Regulation of monocyte chemotactic protein-1 production
Process GO:0071639 Positive regulation of monocyte chemotactic protein-1 production
Process GO:0071702 Organic substance transport
Process GO:0071704 Organic substance metabolic process
Process GO:0071705 Nitrogen compound transport
Process GO:0071900 Regulation of protein serine/threonine kinase activity
Process GO:0071902 Positive regulation of protein serine/threonine kinase activity
Process GO:0072359 Circulatory system development
Process GO:0072594 Establishment of protein localization to organelle
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0090237 Regulation of arachidonic acid secretion
Process GO:0090322 Regulation of superoxide metabolic process
Process GO:0090330 Regulation of platelet aggregation
Process GO:0097529 Myeloid leukocyte migration
Process GO:0097530 Granulocyte migration
Process GO:0098542 Defense response to other organism
Process GO:0098609 Cell-cell adhesion
Process GO:0120161 Regulation of cold-induced thermogenesis
Process GO:0120162 Positive regulation of cold-induced thermogenesis
Process GO:0140029 Exocytic process
Process GO:0140352 Export from cell
Process GO:1900084 Regulation of peptidyl-tyrosine autophosphorylation
Process GO:1900086 Positive regulation of peptidyl-tyrosine autophosphorylation
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901576 Organic substance biosynthetic process
Process GO:1901698 Response to nitrogen compound
Process GO:1902105 Regulation of leukocyte differentiation
Process GO:1902107 Positive regulation of leukocyte differentiation
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902563 Regulation of neutrophil activation
Process GO:1903037 Regulation of leukocyte cell-cell adhesion
Process GO:1903039 Positive regulation of leukocyte cell-cell adhesion
Process GO:1903131 Mononuclear cell differentiation
Process GO:1903305 Regulation of regulated secretory pathway
Process GO:1903307 Positive regulation of regulated secretory pathway
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903530 Regulation of secretion by cell
Process GO:1903532 Positive regulation of secretion by cell
Process GO:1903555 Regulation of tumor necrosis factor superfamily cytokine production
Process GO:1903557 Positive regulation of tumor necrosis factor superfamily cytokine production
Process GO:1903706 Regulation of hemopoiesis
Process GO:1903708 Positive regulation of hemopoiesis
Process GO:1905952 Regulation of lipid localization
Process GO:1990266 Neutrophil migration
Process GO:1990840 Response to lectin
Process GO:1990849 Vacuolar localization
Process GO:1990858 Cellular response to lectin
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000116 Regulation of cysteine-type endopeptidase activity
Process GO:2000191 Regulation of fatty acid transport
Process GO:2000377 Regulation of reactive oxygen species metabolic process
Process GO:2000379 Positive regulation of reactive oxygen species metabolic process
Process GO:2001056 Positive regulation of cysteine-type endopeptidase activity
Process GO:2001141 Regulation of RNA biosynthetic process
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005737 Cytoplasm
Component GO:0005829 Cytosol
Component GO:0005886 Plasma membrane
Component GO:0009898 Cytoplasmic side of plasma membrane
Component GO:0016020 Membrane
Component GO:0019814 Immunoglobulin complex
Component GO:0019815 B cell receptor complex
Component GO:0019897 Extrinsic component of plasma membrane
Component GO:0019898 Extrinsic component of membrane
Component GO:0030139 Endocytic vesicle
Component GO:0031234 Extrinsic component of cytoplasmic side of plasma membrane
Component GO:0031410 Cytoplasmic vesicle
Component GO:0031982 Vesicle
Component GO:0032009 Early phagosome
Component GO:0032991 Protein-containing complex
Component GO:0042101 T cell receptor complex
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043235 Receptor complex
Component GO:0045335 Phagocytic vesicle
Component GO:0071944 Cell periphery
Component GO:0097708 Intracellular vesicle
Component GO:0098552 Side of membrane
Component GO:0098562 Cytoplasmic side of membrane
Component GO:0098796 Membrane protein complex
Component GO:0098797 Plasma membrane protein complex
Component GO:0098802 Plasma membrane signaling receptor complex
Component GO:0110165 Cellular anatomical entity
Function GO:0000166 Nucleotide binding
Function GO:0001784 Phosphotyrosine residue binding
Function GO:0003824 Catalytic activity
Function GO:0004672 Protein kinase activity
Function GO:0004674 Protein serine/threonine kinase activity
Function GO:0004713 Protein tyrosine kinase activity
Function GO:0004715 Non-membrane spanning protein tyrosine kinase activity
Function GO:0005102 Signaling receptor binding
Function GO:0005126 Cytokine receptor binding
Function GO:0005178 Integrin binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0005524 ATP binding
Function GO:0016170 interleukin-15 receptor binding
Function GO:0016301 Kinase activity
Function GO:0016740 Transferase activity
Function GO:0016772 Transferase activity, transferring phosphorus-containing groups
Function GO:0016773 Phosphotransferase activity, alcohol group as acceptor
Function GO:0017076 Purine nucleotide binding
Function GO:0019899 Enzyme binding
Function GO:0019900 Kinase binding
Function GO:0019901 Protein kinase binding
Function GO:0019902 Phosphatase binding
Function GO:0019904 Protein domain specific binding
Function GO:0030554 Adenyl nucleotide binding
Function GO:0031625 Ubiquitin protein ligase binding
Function GO:0032553 Ribonucleotide binding
Function GO:0032555 Purine ribonucleotide binding
Function GO:0032559 Adenyl ribonucleotide binding
Function GO:0035325 Toll-like receptor binding
Function GO:0035639 Purine ribonucleoside triphosphate binding
Function GO:0036094 Small molecule binding
Function GO:0042169 SH2 domain binding
Function GO:0043167 Ion binding
Function GO:0043168 Anion binding
Function GO:0043274 Phospholipase binding
Function GO:0044389 Ubiquitin-like protein ligase binding
Function GO:0044877 Protein-containing complex binding
Function GO:0045309 Protein phosphorylated amino acid binding
Function GO:0050839 Cell adhesion molecule binding
Function GO:0051219 Phosphoprotein binding
Function GO:0097110 Scaffold protein binding
Function GO:0097159 Organic cyclic compound binding
Function GO:0097367 Carbohydrate derivative binding
Function GO:0140096 Catalytic activity, acting on a protein
Function GO:1901265 Nucleoside phosphate binding
Function GO:1901363 Heterocyclic compound binding

Pathway annotation


Category Term ID Term description
RCTM RNO-109582 Hemostasis
RCTM RNO-114604 GPVI-mediated activation cascade
RCTM RNO-1280215 Cytokine Signaling in Immune system
RCTM RNO-1280218 Adaptive Immune System
RCTM RNO-162582 Signal Transduction
RCTM RNO-168249 Innate Immune System
RCTM RNO-168256 Immune System
RCTM RNO-2029480 Fcgamma receptor (FCGR) dependent phagocytosis
RCTM RNO-2029481 FCGR activation
RCTM RNO-2029482 Regulation of actin dynamics for phagocytic cup formation
RCTM RNO-2029485 Role of phospholipids in phagocytosis
RCTM RNO-2172127 DAP12 interactions
RCTM RNO-2424491 DAP12 signaling
RCTM RNO-2454202 Fc epsilon receptor (FCERI) signaling
RCTM RNO-2730905 Role of LAT2/NTAL/LAB on calcium mobilization
RCTM RNO-2871796 FCERI mediated MAPK activation
RCTM RNO-2871809 FCERI mediated Ca+2 mobilization
RCTM RNO-354192 Integrin signaling
RCTM RNO-449147 Signaling by Interleukins
RCTM RNO-512988 Interleukin-3, Interleukin-5 and GM-CSF signaling
RCTM RNO-5621480 Dectin-2 family
RCTM RNO-5621481 C-type lectin receptors (CLRs)
RCTM RNO-76002 Platelet activation, signaling and aggregation
RCTM RNO-76009 Platelet Aggregation (Plug Formation)
RCTM RNO-912631 Regulation of signaling by CBL
RCTM RNO-9607240 FLT3 Signaling
RCTM RNO-9674555 Signaling by CSF3 (G-CSF)
RCTM RNO-9705462 Inactivation of CSF3 (G-CSF) signaling
RCTM RNO-9706374 FLT3 signaling through SRC family kinases
RCTM RNO-983695 Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
RCTM RNO-983705 Signaling by the B Cell Receptor (BCR)
WikiPathways WP319 IL-3 signaling pathway
WikiPathways WP44 IL-5 signaling pathway
WikiPathways WP5057 Burn wound healing
WikiPathways WP569 IL-2 signaling pathway
KEGG rno04064 NF-kappa B signaling pathway
KEGG rno04072 Phospholipase D signaling pathway
KEGG rno04151 PI3K-Akt signaling pathway
KEGG rno04380 Osteoclast differentiation
KEGG rno04611 Platelet activation
KEGG rno04613 Neutrophil extracellular trap formation
KEGG rno04625 C-type lectin receptor signaling pathway
KEGG rno04650 Natural killer cell mediated cytotoxicity
KEGG rno04662 B cell receptor signaling pathway
KEGG rno04664 Fc epsilon RI signaling pathway
KEGG rno04666 Fc gamma R-mediated phagocytosis
KEGG rno05152 Tuberculosis
KEGG rno05167 Kaposi sarcoma-associated herpesvirus infection
KEGG rno05168 Herpes simplex virus 1 infection
KEGG rno05169 Epstein-Barr virus infection
KEGG rno05171 Coronavirus disease - COVID-19
KEGG rno05203 Viral carcinogenesis

Expression profile of Syk in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 5.400484533333334
GSM2685202 MX2 tissue: Myocardium gender: female 5.089679633333334
GSM2685203 MX3 tissue: Myocardium gender: female 5.244521266666666
GSM2685204 MX4 tissue: Myocardium gender: male 5.1863683
GSM2685205 DZ1 tissue: Myocardium gender: male 5.729846266666667
GSM2685206 DZ2 tissue: Myocardium gender: male 5.3225093
GSM2685207 DZ3 tissue: Myocardium gender: female 5.2051872999999995
GSM2685208 DZ4 tissue: Myocardium gender: female 5.4493366666666665
GSM2685209 JJ1 tissue: Myocardium gender: male 5.310448966666667
GSM2685210 JJ2 tissue: Myocardium gender: female 5.297881933333334
GSM2685211 JJ3 tissue: Myocardium gender: female 5.189726
GSM2685212 JJ4 tissue: Myocardium gender: male 5.2354598999999995
GSM2685213 NG1 tissue: Myocardium gender: male 5.0204506
GSM2685214 NG2 tissue: Myocardium gender: female 5.257693833333334
GSM2685215 NG3 tissue: Myocardium gender: male 5.311125466666667
GSM2685216 NG4 tissue: Myocardium gender: female 5.1920117333333335
GSM2685217 YL1 tissue: Myocardium gender: male 5.350155633333333
GSM2685218 YL2 tissue: Myocardium gender: male 5.2461899999999995
GSM2685219 YL3 tissue: Myocardium gender: female 5.1594150999999995
GSM2685220 YL4 tissue: Myocardium gender: female 5.2647096
GSM2685221 QC1 tissue: Myocardium gender: male 4.848256566666667
GSM2685222 QC2 tissue: Myocardium gender: male 5.189629666666666
GSM2685223 QC3 tissue: Myocardium gender: female 5.2900537000000005
GSM2685224 QC4 tissue: Myocardium gender: female 5.892446766666667

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.910082275
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.873703136
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.818301249
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.749336793
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.750749719
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.942739658

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 115.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 67.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 127.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 127.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 86.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 81.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 94.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 175.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 96.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 131.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 99.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 152.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 119.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 98.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 119.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 108.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.88207
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.958763
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.929701
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.09394
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.883198
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.938572

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 4.985
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 5.645
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 7.59
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 3.666
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 2.835

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 6.407568928
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 7.061775714
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 6.690510852

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 144.75
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 42.300000000000004
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 78.75
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 33.8
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 26.25
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 70.55
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 63.55
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 29.549999999999997
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 44.349999999999994
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 103.8
GSM27494 CTL_a (control, 1st replicate) 26.35
GSM27495 CTL_b (control, 2nd replicate) 25.1
GSM27496 CTL_c (control, 3rd replicate) 106.85000000000001
GSM27497 CTL_d (control, 4th replicate) 45.55
GSM27498 CTL_e (control, 5th replicate) 21.45
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 70.69999999999999
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 31.55
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 36.849999999999994
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 37.4
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 35.7
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 59.0
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 108.55
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 27.700000000000003
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 47.650000000000006
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 73.85
GSM27509 ISCH_a (ischemia, 1st replicate) 26.200000000000003
GSM27510 ISCH_b (ischemia, 2nd replicate) 52.349999999999994
GSM27511 ISCH_c (ischemia, 3rd replicate) 50.75
GSM27512 ISCH_d (ischemia, 4th replicate) 30.0
GSM27513 ISCH_e (ischemia, 5th replicate) 97.55

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 186.8
GSM30791 baseline control 02 male, 275-300g 216.4
GSM30792 baseline control 03 male, 275-300g 155.1
GSM30793 baseline control 04 male, 275-300g 184.0
GSM30794 baseline control 05 male, 275-300g 146.2
GSM30795 baseline control 06 male, 275-300g 160.8
GSM30796 baseline control 07 male, 275-300g 167.3
GSM30797 baseline control 08 male, 275-300g 155.9
GSM30798 baseline control 09 male, 275-300g 145.4
GSM30799 pain 01 210.0
GSM30800 pain 02 246.7
GSM30801 pain 03 314.6
GSM30802 pain 04 141.5
GSM30803 pain 05 164.2
GSM30804 FC 01 151.1
GSM30805 FC 02 236.7
GSM30806 FC 03 181.3
GSM30807 FC 04 166.3
GSM30808 FC 05 222.8
GSM30809 IFC 01 121.7
GSM30810 IFC 02 186.4
GSM30811 IFC 03 196.1
GSM30812 IFC 04 177.8
GSM30813 IFC 05 146.0
GSM99800 isoflurane 01 male, 275-300g 151.2
GSM99801 isoflurane 02 male, 275-300g 251.2
GSM99802 isoflurane 03 male, 275-300g 183.3
GSM99803 isoflurane 04 male, 275-300g 214.5
GSM99804 isoflurane 05 male, 275-300g 271.3

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 63.9572
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 53.9492
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 50.0587
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 45.0939
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 58.2761
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 38.7893
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 98.3866
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 91.4924
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 107.5713

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 4.52135
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 4.05277
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 3.75987
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 3.99085
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 4.55879
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 5.57115
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 4.33969
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 4.4928
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 3.92419
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 4.39209
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 4.44363
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 3.93253
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 4.56505
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 5.14121
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 4.54999
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 4.00387

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.000638
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.010723
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.896308
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.920979
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.050455
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.813607
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.913984
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.747985
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.715904
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.669711
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.885876
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.932252
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.809893
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.83018
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.920589
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.707154
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.878092
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.855061
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.920683
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.907992
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.786973
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.756778
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.93752
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.919757
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.703522
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.778836
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.968054
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.798095
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.682203
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.618194
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.572433
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.749945
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.833136
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.637711
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.880991
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.755995
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.504296
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.710969
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.782146
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.648297
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.820656
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.870144
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.647691
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.816078
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.673543

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 42.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 30.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 39.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 44.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 37.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 37.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 45.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 29.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 36.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 58.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 30.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 45.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 34.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 46.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 38.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 47.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 33.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 38.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 30.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 39.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 52.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 69.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 49.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 43.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 38.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 43.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 41.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 41.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 49.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 75.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 53.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 54.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 51.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 47.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 46.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 43.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 4.383904
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 2.548547
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 3.781979
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 3.808524

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; 0.0128
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.0337
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 -0.0262
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.111
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.036
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.00364
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 -0.0271
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 0.00664
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 -0.0441
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 -0.0145
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 -0.102
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 -0.00481

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 18.299999999999997
GSM5121 Isoflurane single exposure control-2 25.55
GSM5122 Isoflurane single exposure control-3 7.55
GSM5124 Isoflurane single exposure 1 hr-1 9.0
GSM5126 Isoflurane single exposure 1 hr-2 19.45
GSM5127 Isoflurane single exposure 2 hr-1 20.25
GSM5130 Isoflurane single exposure 2 hr-2 28.900000000000002
GSM5131 Isoflurane single exposure 2 hr-3 17.450000000000003

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 9.018651031
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 9.364061614
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 8.44915726
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 8.536219754
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.871965969
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.514537999
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 9.252395011
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 8.858980606
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 8.852712958
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 8.891137142
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 9.283244427
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.801628983
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 8.552285517
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 8.730624027
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 8.671140606
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 8.613431363
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 9.399187815
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 8.415094369
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 8.637812707
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 8.331366859
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.675315806
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.630661927
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 8.615942043
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 8.31256435

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.056251
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.163928
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.177194
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.064563
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.228515
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.295688
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.204745
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.090935
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.219144
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.011736
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.117913
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.370717
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.357957
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.475115
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.279198
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.097142
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.246018
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.346401
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.267288
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.040944
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.202505
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.429079
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.377985
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.173624

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 132.1049
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 142.1691

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1397.097034
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1725.573402
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1783.7405
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 2000.188129
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 1292.565568
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 2915.597241
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1702.109418
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1750.613446
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1624.833289
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 2262.330614
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 2088.072919
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1898.907365
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1356.136024
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 2526.240226

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 9.018651031
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 9.364061614
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 8.44915726
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 8.536219754
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.871965969
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.514537999
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 9.252395011
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 8.858980606
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 8.852712958
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 8.891137142
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 9.283244427
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.801628983
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 8.552285517
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 8.730624027
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 8.671140606
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 8.613431363
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 9.399187815
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 8.415094369
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 8.637812707
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 8.331366859
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.675315806
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.630661927
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 8.615942043
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 8.31256435
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 1397.097034
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1725.573402
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1783.7405
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 2000.188129
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 1292.565568
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 2915.597241
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 1702.109418
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1750.613446
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1624.833289
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 2262.330614
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 2088.072919
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1898.907365
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1356.136024
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 2526.240226

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 36.550000000000004
GSM5084 Control 2 31.75
GSM5085 Control 3 14.95
GSM5086 Control 4 23.700000000000003
GSM5087 Control 5 33.1
GSM5090 Control 6 30.85
GSM5105 Control 7 27.549999999999997
GSM5106 Control 8 28.35
GSM5107 Control 9 42.099999999999994
GSM5108 Halothane 10 exposure-1 16.7
GSM5109 Halothane 10 exposures-2 12.75
GSM5110 Halothane 10 exposures-3 25.25
GSM5111 Halothane 5 exposures-1 32.05
GSM5112 Halothane 5 exposures-2 31.85
GSM5113 Halothane 5 exposures-3 26.7
GSM5114 Isoflurane 10 exposures-1 18.35
GSM5115 Isoflurane 10 exposures-2 33.7
GSM5116 Isoflurane 10 exposures-3 35.75
GSM5117 Isoflurane 5 exposures-1 26.75
GSM5118 Isoflurane 5 exposures-2 24.15
GSM5119 Isoflurane 5 exposures-3 33.55
GSM11379 Control 10 35.75
GSM11380 Control 11 80.05
GSM11381 Control 12 30.4

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 48.6902
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 21.7793